Ameriprise Financial Inc Crispr Therapeutics Ag Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ameriprise Financial Inc holds 186,761 shares of CRSP stock, worth $7.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186,761
Previous 162,877 14.66%
Holding current value
$7.41 Million
Previous $8.8 Million 0.24%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$44.62 - $62.75 $1.07 Million - $1.5 Million
23,884 Added 14.66%
186,761 $8.78 Million
Q2 2024

Aug 14, 2024
BUY
$51.17 - $68.18 $311,932 - $415,625
6,096 Added 3.89%
162,877 $8.8 Million
Q1 2024

May 15, 2024
BUY
$60.67 - $89.12 $1.75 Million - $2.57 Million
28,887 Added 22.59%
156,781 $10.7 Million
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $483,522 - $903,693
12,520 Added 10.85%
127,894 $8.01 Million
Q3 2023

Nov 14, 2023
SELL
$45.39 - $59.0 $632,963 - $822,755
-13,945 Reduced 10.78%
115,374 $5.24 Million
Q2 2023

Aug 14, 2023
BUY
$43.47 - $67.77 $2 Million - $3.11 Million
45,941 Added 55.1%
129,319 $7.26 Million
Q1 2023

May 15, 2023
BUY
$41.0 - $56.12 $1.07 Million - $1.46 Million
25,994 Added 45.3%
83,378 $3.77 Million
Q4 2022

Feb 14, 2023
SELL
$39.19 - $65.67 $1.84 Million - $3.09 Million
-46,985 Reduced 45.02%
57,384 $2.33 Million
Q3 2022

Nov 14, 2022
BUY
$61.1 - $83.78 $2.76 Million - $3.79 Million
45,237 Added 76.5%
104,369 $6.9 Million
Q2 2022

Aug 15, 2022
BUY
$43.23 - $73.83 $228,946 - $391,003
5,296 Added 9.84%
59,132 $3.59 Million
Q1 2022

May 16, 2022
BUY
$53.19 - $79.24 $420,679 - $626,709
7,909 Added 17.22%
53,836 $3.38 Million
Q4 2021

Feb 14, 2022
SELL
$70.09 - $111.29 $20.4 Million - $32.4 Million
-290,766 Reduced 86.36%
45,927 $3.48 Million
Q3 2021

Nov 15, 2021
SELL
$110.2 - $156.64 $8,485 - $12,061
-77 Reduced 0.02%
336,693 $37.7 Million
Q2 2021

Aug 16, 2021
SELL
$100.84 - $161.89 $13.1 Million - $21 Million
-129,522 Reduced 27.78%
336,770 $54.5 Million
Q1 2021

May 17, 2021
BUY
$110.72 - $210.04 $1.93 Million - $3.65 Million
17,396 Added 3.88%
466,292 $56.8 Million
Q4 2020

Feb 12, 2021
SELL
$79.67 - $173.23 $14.4 Million - $31.4 Million
-181,267 Reduced 28.77%
448,896 $68.5 Million
Q3 2020

Nov 16, 2020
SELL
$78.5 - $100.64 $34.3 Million - $43.9 Million
-436,415 Reduced 40.92%
630,163 $52.6 Million
Q2 2020

Aug 14, 2020
BUY
$38.5 - $76.05 $9.64 Million - $19 Million
250,371 Added 30.67%
1,066,578 $78.4 Million
Q1 2020

May 15, 2020
BUY
$33.68 - $62.53 $11.7 Million - $21.7 Million
346,434 Added 73.74%
816,207 $34.6 Million
Q4 2019

Feb 14, 2020
BUY
$36.68 - $73.13 $16.5 Million - $32.9 Million
449,202 Added 2183.67%
469,773 $28.6 Million
Q3 2019

Nov 14, 2019
SELL
$40.99 - $52.56 $1,516 - $1,944
-37 Reduced 0.18%
20,571 $843,000
Q2 2019

Aug 14, 2019
SELL
$35.45 - $48.2 $116,240 - $158,047
-3,279 Reduced 13.73%
20,608 $971,000
Q1 2019

May 15, 2019
BUY
$28.02 - $40.87 $34,016 - $49,616
1,214 Added 5.35%
23,887 $853,000
Q4 2018

Feb 14, 2019
SELL
$22.73 - $42.34 $587,047 - $1.09 Million
-25,827 Reduced 53.25%
22,673 $648,000
Q3 2018

Nov 14, 2018
SELL
$44.35 - $65.71 $173,053 - $256,400
-3,902 Reduced 7.45%
48,500 $2.15 Million
Q2 2018

Aug 14, 2018
BUY
$42.62 - $73.59 $1.08 Million - $1.86 Million
25,269 Added 93.13%
52,402 $2.99 Million
Q1 2018

May 15, 2018
BUY
$23.52 - $58.17 $638,168 - $1.58 Million
27,133 New
27,133 $1.17 Million

Others Institutions Holding CRSP

# of Institutions
489
Shares Held
57.9M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.1B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email